Birmingham J R, Chesnut R W, Kappler J W, Marrack P, Kubo R, Grey H M
J Immunol. 1982 Mar;128(3):1491-2.
We have investigated the ability of an Ia-, nonantigen-presenting macrophage tumor cell line, P388D, (H-2d), to present antigen to T cell hybridomas after incubation in a lymphokine-containing preparation. P388D, cells were incubated in microtiter wells with various concentrations of Con A-stimulated spleen cell supernatants. Antigen-specific stimulation of H-2d-restricted, KLH-specific T cell hybridomas was observed by P388D1 incubated with SUP.P388D1 cells incubated for 3 days in medium or control SUP did not present antigen. In addition, no stimulation of T hybridomas was seen by P388D1 in the inhibited by the appropriate monoclonal anti-Ia reagents. These results demonstrate that a macrophage tumor cell line can be induced to present antigen and provides for large numbers of readily available, homogeneous macrophages for studying the cellular biochemical requirements for antigen processing and presentation.
我们研究了一种Ia阴性、不呈递抗原的巨噬细胞肿瘤细胞系P388D(H-2d)在含淋巴因子的制剂中孵育后向T细胞杂交瘤呈递抗原的能力。将P388D细胞在微量滴定板孔中与不同浓度的刀豆蛋白A刺激的脾细胞上清液一起孵育。用与SUP一起孵育的P388D1观察到对H-2d限制的、钥孔戚血蓝蛋白特异性T细胞杂交瘤的抗原特异性刺激。在培养基中孵育3天的P388D1细胞或对照SUP不呈递抗原。此外,P388D1对T杂交瘤没有刺激作用,适当的单克隆抗Ia试剂可抑制这种刺激作用。这些结果表明,巨噬细胞肿瘤细胞系可被诱导呈递抗原,并为研究抗原加工和呈递的细胞生化要求提供了大量易于获得的、同质的巨噬细胞。